Throughout its history, the ICR has achieved numerous milestones in cancer research. Some of its most notable achievements include the discovery of the BRCA2 gene, which is linked to breast and ovarian cancer, and the development of the first genetically targeted cancer drug, gefitinib, for lung cancer. These breakthroughs have significantly advanced our understanding of cancer and improved patient outcomes.
